Novavax Inc posts $80.95 million revenue in quarter ended Mar 31, 2023
By USInMinutes - May 10, 2023, 01:27 AM ET
Last Updated - Jul 18, 2023, 03:32 PM EDT
Key fundamental financials
loss of $293.90 million
Revenue of $80.95 million
Novavax Inc [NVAX] has reported $293.90 million loss for the fiscal quarter ending Mar 31, 2023.
Revenue for the quarter was $80.95 million with operating income of $312.77 million.
The Columbia, Maryland (MD)-based company operating in the biological products, except diagnostic substances sector has total shareholders equity of $895.58 million.
